Teva Pharmaceuticals USA, Inc vs Viatris, Inc.: FDA Enforcement Comparison

Teva Pharmaceuticals USA, Inc has been the subject of 41 FDA enforcement/approval records tracked by Argus HQ, compared to 18 for Viatris, Inc..

Teva Pharmaceuticals USA, Inc: 0 warning letters, 39 recalls, 2 approval records, 0 Form 483s.

Viatris, Inc.: 0 warning letters, 18 recalls, 0 approval records, 0 Form 483s.

Side by side

Teva Pharmaceuticals USA, Inc — Warning letters0

Viatris, Inc. — Warning letters0

Teva Pharmaceuticals USA, Inc — Recalls39

Viatris, Inc. — Recalls18

Teva Pharmaceuticals USA, Inc — Approval records2

Viatris, Inc. — Approval records0

Teva Pharmaceuticals USA, Inc — Form 483s0

Viatris, Inc. — Form 483s0

Timeline

Teva Pharmaceuticals USA, Inc

Most recent FDA action: June 26, 2026

Full history →

Viatris, Inc.

Most recent FDA action: April 15, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Teva Pharmaceuticals USA, Inc vs Viatris, Inc.: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/teva-pharmaceuticals-usa-inc-vs-viatris-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗